BBOT · BridgeBio Oncology Therapeutics, Inc. · Documents
Market Cap
$314.28M
Shares
80.17M
Volume · Oct 5
481.65K
Avg daily vol (3M)
467.53K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-08 | — | |
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-06-22 | 2026-06-16 | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-04-29 | 2026-04-27 | |
| DEF 14A | 2026-04-28 | 2026-06-16 | |
| 8-K | 2026-04-23 | 2026-04-20 | |
| 8-K | 2026-03-26 | 2026-03-24 | |
| 8-K | 2026-03-05 | — | |
| 10-K | 2026-03-05 | 2025-12-31 | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-08-13 | 2025-08-11 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-08-04 | — | |
| 10-Q | 2025-08-01 | 2025-06-30 | |
| 8-K | 2025-07-11 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 10-K | 2025-03-11 | 2024-12-31 | |
| 8-K | 2025-03-03 | 2025-02-28 | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-02-10 | 2025-02-08 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 8-K | 2024-02-20 | 2024-02-13 | |
| 8-K | 2024-02-14 | 2024-02-08 |
Showing 1–30 of 30 filings